NCT07700095 Three-Dimensional Bone Augmentation of Severely Atrophied Posterior Mandibular Alveolar Ridges Using Customized-3D Zirconia Barriers Versus Pre-bent Titanium Mesh
| NCT ID | NCT07700095 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hams Hamed Abdelrahman |
| Condition | Mandibular Atrophy |
| Study Type | INTERVENTIONAL |
| Enrollment | 16 participants |
| Start Date | 2024-08-03 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 16 participants in total. It began in 2024-08-03 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Zirconia can be considered as an alternative and innovative material suitable for GBR because it has high biocompatibility, together with a scarce tissue integration. Zirconia barriers could be a predictable and alternative barrier material for GBR in terms of (i) biocompatibility, (ii) ease of use and removal, (iii) exposure management, (iv) bone regeneration outcomes.
Eligibility Criteria
Inclusion Criteria: * Patients are systemically medically free according to the American Society of Anesthesiologists (ASA) considered as ASA I. * Ability to maintain good oral hygiene as evidenced in recall visits. * patients who had a partial or completely edentulous alveolar ridge with apparent 3D defect following teeth loss. * All patients were free from any local or general disease that may interfere with bone healing and had no history of previous grafting procedure at the designated edentulous ridge. * The ridge had to exhibit severe vertical and horizontal (3D) alveolar ridge deficiency with alveolar ridge height less than 7 mm from the alveolar crest to the inferior alveolar canal and width less than 5 mm which was firstly measured by CBCT, or a clinically apparent increase in inter-arch space relative to the adjacent natural teeth. * Pre-operative clinical assessment of soft tissue coverage was done to cover the graft and its membrane, in addition to assessment of occlusion and inter-arch distance should allow for the graft, membrane, implan and the future prosthesis. Exclusion Criteria: * Smoker (\> 25 cigarettes/ day). * Patients undergoing radiotherapy or chemotherapy * Patients having infection or local lesions in the area of surgery. * Patients with diabetes mellitus or bone diseases which may compromise the results. * Patient with poor oral hygiene or active periodontal disease. * Patient with limited mouth opening. * Participation in other clinical trials
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07700095 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 50 Years, studying Mandibular Atrophy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07700095 currently recruiting?
Yes, NCT07700095 is actively recruiting participants. Contact the research team at Mo3taznasr@gmail.com for enrollment information.
Where is the NCT07700095 trial being conducted?
This trial is being conducted at Kafr Elsheikh, Egypt.
Who is sponsoring the NCT07700095 clinical trial?
NCT07700095 is sponsored by Hams Hamed Abdelrahman. The trial plans to enroll 16 participants.